Product Image

Brain Charge

Source Naturals
4.5
★ ★ ★ ★ ★
(363 ratings)
Huperzine 150 mcg
Vinpocetine 30 mg
Acetyl L-Carnitine 750 mg
Vitamin B6 50 mg
Niacin 50 mg
Vitamin B5 50 mg
Deanol 130 mg
Product Image
Score70
A broad and meaningfully dosed cognitive stack with stronger pathway coverage than most blends. Its high B6, vinpocetine, huperzine A, and interaction burden demand careful use.
How scoring works
Quantity:60 Tablet(s) • (15 servings)
Goals:
Mental Focus
Anti-Aging
Brain Health
Productivity Boost
Energy
Cognitive Support
Metabolism Boost
General Health

Score 70

A broad and meaningfully dosed cognitive stack with stronger pathway coverage than most blends. Its high B6, vinpocetine, huperzine A, and interaction burden demand careful use.
How scoring works
$24.49($1.63 per serving)
iHerb
$ 24.49
Report prices

Analysis

The formula reaches memory, attention, cellular energy, stress resilience, and cerebral-circulation pathways through a large group of relevant actives. Acetyl-L-carnitine, alpha-glycerophosphocholine, phosphatidylserine, ginkgo, rhodiola, and huperzine A provide the most meaningful cognitive core.

Many quantities are substantial and individually listed, which is a strength for such a complex blend. Several botanical extracts lack marker percentages, while some supporting ingredients are modest and vitamin B6 is unusually high for daily maintenance.

Experienced users seeking broad cognitive coverage may value the depth, provided they can manage a four-tablet serving and interaction risks. Pregnancy, anticoagulant use, cholinergic medicines, and long-term unsupervised use are poor fits because of vinpocetine, ginkgo, huperzine A, and high B6.

Who is it for
  • Experienced supplement users seeking multi-pathway cognitive support
  • Adults comfortable with a large tablet serving and complex formula
Best for
  • Broad memory and focus support
  • Combining choline, circulation, adaptogen, and mitochondrial pathways

Pros

  • Deep cognitive ingredient coverage
  • Substantial acetyl-L-carnitine and gotu kola amounts
  • Includes alpha-GPC and phosphatidylserine
  • Most active weights are disclosed
  • Uses methylcobalamin

Cons

  • Four-tablet serving
  • Several extracts lack standardization percentages
  • Vitamin B6 is high for long-term use
  • Many actives increase interaction complexity
  • Some supporting doses are modest within the large stack

Warnings

  • Vinpocetine should not be used during pregnancy because it may harm fetal development.
  • Vitamin B6 at 50 mg may raise the risk of nerve symptoms with prolonged daily use.
  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.
  • Huperzine A may interact with cholinergic or anticholinergic medicines and can cause nausea, vivid dreams, or a slow heart rate.
  • Niacin may cause flushing, while the broad adaptogen stack may not suit people with bipolar disorder.

Nutrient quality

72 High impact

Several bioactive or targeted forms and meaningful nootropic doses create impressive breadth. High B-vitamin amounts and inconsistent extract standardization are important limitations.

Ingredient transparency

80 Highest impact

Almost every active has a specific amount and no proprietary blend is used. Botanical markers, inactive ingredients, and detailed use guidance are still incomplete.

Customer satisfaction

68 High impact

The aggregate rating is favorable and supported by substantial feedback volume. No detailed comments are supplied to reveal recurring tolerance or performance issues.

Value for money

57 Moderate impact

The extensive active stack partly supports the premium price. A high serving cost and several modest or weakly specified ingredients reduce category competitiveness.

Report analysis

Goals

Mental Focus
Mental Focus
Impact
Highest effect
A- Goal FitB+ Strength of SupportA CoverageB+ Formula Quality
Folate · 340 mcg DFEVitamin B6 · 50 mgVitamin B12 · 200 mcgAcetyl L-Carnitine · 750 mgHuperzine · 150 mcg

Acetyl-L-carnitine, glycerophosphatidylcholine, phosphatidylserine, ginkgo, huperzine A, and adaptogens make this a deeply targeted cognitive formula. Several lead amounts are well aligned, although botanical standardization remains incomplete.

The combination covers energy, cholinergic signaling, cell membranes, circulation, and stress resilience with useful depth. Ginkgo and vinpocetine may increase concern with blood-thinning medicines, while huperzine A can interact with cholinergic or anticholinergic drugs.

Study evidence
Acetyl L-Carnitine Supportive 7 studies
Ginkgo Supportive 28 studies
Huperzine Not classified

No linked studies yet.

Vinpocetine Supportive 3 studies
Anti-Aging
Anti-Aging
Impact
Highest effect
A- Goal FitA- Strength of SupportA- CoverageB+ Formula Quality
Coenzyme Q-10 · 50 mgFolate · 340 mcg DFEVitamin B12 · 200 mcg

Acetyl-L-carnitine, phosphatidylserine, CoQ10, alpha-lipoic acid, rhodiola, ashwagandha, and ginkgo target cognitive, mitochondrial, and stress-related aging pathways. Several lead actives reach meaningful disclosed amounts.

The formula is broad but remains centered on brain health rather than scattering into unrelated wellness themes. Vinpocetine is a concern for anyone pregnant or who could become pregnant, while 50 mg pyridoxine warrants caution with prolonged use.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Ashwagandha No effect 1 study
Brain Health
Brain Health
Impact
Highest effect
A- Goal FitB Strength of SupportA CoverageB Formula Quality
Folate · 340 mcg DFEVitamin B12 · 200 mcgVitamin B6 · 50 mgThiamin · 15 mgAshwagandha · 250 mgHuperzine · 150 mcg

Acetyl L-carnitine, phospholipid ingredients, ginkgo, vinpocetine, huperzine A, rhodiola, and ashwagandha provide unusually complete cognitive coverage. Several central doses are clinically plausible, though botanical standardization is inconsistent.

The formula balances energy, membrane support, circulation, acetylcholine, and stress resilience better than most broad stacks. Ginkgo and vinpocetine may matter with anticoagulant or antiplatelet medicines, while huperzine A can interact with cholinergic or anticholinergic drugs.

Study evidence
Acetyl L-Carnitine Supportive 19 studies
Ashwagandha Supportive 12 studies
Ginkgo Supportive 90 studies
Huperzine Supportive 17 studies
Vinpocetine Supportive 7 studies
Productivity Boost
Productivity Boost
Impact
Highest effect
A- Goal FitB Strength of SupportA CoverageB Formula Quality
Vitamin B12 · 200 mcgVitamin B12 · 200 mcgVitamin B6 · 50 mgAcetyl L-Carnitine · 750 mgAcetyl L-Carnitine · 750 mgVinpocetine · 30 mgHuperzine · 150 mcg

Acetyl-L-carnitine, phosphatidyl compounds, adaptogens, ginkgo, vinpocetine, huperzine A, and tyrosine directly target multiple productivity pathways. Acetyl-L-carnitine, gotu kola, ginkgo, vinpocetine, and huperzine A reach meaningful disclosed amounts.

The formula covers cellular energy, membrane and cholinergic support, circulation, stress response, and neurotransmitter synthesis. Most pathways have credible depth, while tyrosine and phosphatidylserine are somewhat lighter than the strongest components.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Acetyl L-Carnitine Supportive 1 study
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Huperzine No effect 1 study
Energy
Energy
Impact
Highest effect
A Goal FitB+ Strength of SupportA- CoverageC+ Formula Quality
Vitamin B5 · 50 mgRiboflavin · 15 mgThiamin · 15 mgVitamin B12 · 200 mcgAcetyl L-Carnitine · 750 mgCoenzyme Q-10 · 50 mg

Acetyl-L-carnitine, Rhodiola, B vitamins, CoQ10, and several focus compounds address metabolic, stress, and cognitive energy pathways. Useful carnitine and Rhodiola amounts give the broad formula genuine substance.

CoQ10, tyrosine, and several secondary nootropics are modest, while the long ingredient list makes interactions harder to judge. Ginkgo and vinpocetine may increase bleeding concern with anticoagulant or antiplatelet medicines, and huperzine A can interact with cholinergic or anticholinergic drugs.

Study evidence
Acetyl L-Carnitine Supportive 19 studies
Cognitive Support
Cognitive Support
Impact
Highest effect
A- Goal FitB+ Strength of SupportA CoverageB- Formula Quality
Thiamin · 15 mgVitamin B6 · 50 mgFolate · 340 mcg DFEVitamin B12 · 200 mcgHuperzine · 150 mcgAshwagandha · 250 mgAcetyl L-Carnitine · 750 mg

Acetyl-L-carnitine, glycerophosphatidylcholine, phosphatidylserine, ginkgo, rhodiola, ashwagandha, tyrosine, DMAE, vinpocetine, and huperzine A create unusually broad cognitive coverage. Major actives generally reach useful amounts, though several botanical extracts lack marker standardization.

The stack has clear energy, membrane, neurotransmitter, circulation, and stress-resilience logic despite its size. Ginkgo and vinpocetine matter with anticoagulant or antiplatelet medicines, while huperzine A may interact with cholinergic or anticholinergic drugs.

Study evidence
Acetyl L-Carnitine Supportive 20 studies
Ashwagandha Supportive 17 studies
Ginkgo Supportive 87 studies
Huperzine Supportive 22 studies

Ingredients

IngredientAmount per serving
Calories
15 Calorie(s)
Total Carbohydrate
2 Gram(s)
Thiamin
15 mg
Riboflavin
15 mg
Niacin (Niacinamide)
 50 mg
Vitamin B6 (Pyridoxine Hydrochloride)
 50 mg
Folate
340 mcg DFE
Vitamin B12 (Methylcobalamin)
 200 mcg
Biotin
100 mcg
Pantothenic Acid (Calcium D-Pantothenate)
 50 mg
Calcium (Dibasic Calcium Phosphate)
 50 mg
Sodium
15 mg
Acetyl-L-Carnitine (Acetyl-L-Carnitine HCl)
 750 mg
Gotu Kola Whole Plant Extract
750 mg
Ashwagandha root extract
250 mg
Rhodiola root extract
250 mg
Glycerophosphatidylcholine
200 mg
DMAE (DMAE Bitartrate)
 130 mg
Ginkgo leaf extract
120 mg
N-Acetyl L-Tyrosine
100 mg
Grape Seed Extract
100 mg
Sharp PS (Phosphatidylserine)
 90 mg
Coenzyme Q10
50 mg
Vinpocetine
30 mg
Alpha-Lipoic Acid
25 mg
Huperzine A (Huperzia serrata whole plant extract)
 150 mcg
Adults 18–50 Women
Report overview
Huperzine (Huperzia serrata whole plant extract) · 150 mcg OverallScore82
B+ Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyB Value

The disclosed 150 mcg dose of Huperzine A fits the intended range and is delivered in premeasured tablets. Huperzia serrata whole plant extract is named, but the absence of a standardized alkaloid percentage limits confidence in extract consistency. Direct active cost is high, yet alpha-GPC, phosphatidylserine, acetyl L-carnitine, and other complementary ingredients support stronger value as a broad nootropic stack.

View ingredientView products
Vinpocetine · 30 mg OverallScore81
A Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyD+ Value

The vinpocetine dose is clearly disclosed and falls at the top of the standard target range. Requiring four tablets makes the serving less practical, and the provided data does not fully show inactive ingredients. Vinpocetine cost efficiency is weak, though substantial acetyl-L-carnitine, ginkgo, and phospholipid ingredients improve the value of the wider formula.

View ingredientView products
Acetyl L-Carnitine (Acetyl-L-Carnitine HCl) · 750 mg OverallScore79
A- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

ALCAR hydrochloride at 750 mg is clearly disclosed and sits comfortably within the target range. The formula also includes glycerophosphatidylcholine and phosphatidylserine, which improve the case for its high serving cost. Ginkgo and vinpocetine may increase concern with anticoagulant or antiplatelet medicines, and huperzine A may interact with cholinergic or anticholinergic drugs.

View ingredientView products
Loading alternative details
85 Performance

B-Complex Plus

Pure Encapsulations
<p>Methylfolate, methylcobalamin, P-5-P, and activated riboflavin create a more balanced and refined B-vitamin base than the original. It does not reproduce the broad nootropic stack, but the simpler formula avoids vinpocetine, huperzine, ginkgo, and multiple incompletely standardized botanicals.</p>
80 Performance

B-Complex #12

Thorne
<p>A focused methylcobalamin-based B-complex provides substantial nutrient support with far less interaction complexity than the original. It omits the cognitive botanicals, phospholipids, carnitine, tyrosine, and cholinergic agents, while its B6 and niacin amounts still warrant attention.</p>
79 Performance

Coenzyme B-Complex Advanced

Country Life
<p>Active B-vitamin forms plus PQQ create a sophisticated metabolic-energy formula with fewer interacting actives than the original. It gives up direct nootropic coverage from carnitine, ginkgo, phosphatidylserine, huperzine, and adaptogens, while its B6 and niacin amounts remain aggressive.</p>
67 Budget

B 100 Complex

Spring Valley
<p>The very low serving cost provides broad B-vitamin coverage for energy metabolism. It removes every nootropic ingredient in the original, while unspecified forms and excessive vitamin B6 make routine use difficult to assess.</p>
79 Budget

B-100 Complex

21st Century
<p>The inexpensive B-complex retains the original’s high-potency nutrient foundation and long-term energy focus. It omits acetyl-L-carnitine, gotu kola, adaptogens, phospholipids, ginkgo, tyrosine, and cholinergic ingredients, while vitamin B6 remains at an aggressive amount.</p>
80 Budget

B-100 Complex with B2 Coenzyme

Nature's Way
<p>Active riboflavin and partial P-5-P improve part of the B-vitamin base at a much lower serving cost. All of the original’s nootropic and adaptogenic ingredients are absent, and the total vitamin B6 amount remains a long-term concern.</p>
80 Value

B-Complex '100'

Solgar
<p>The large supply and broad B-vitamin profile offer strong serving value for basic energy metabolism. Conventional forms, very high vitamin B6, and the absence of the original’s nootropic ingredients make it simpler but not equivalent.</p>
73 Value

B-50 Gels

Carlson
<p>The full B-complex is clearly dosed and substantially cheaper per serving than the original. It omits all botanical and nootropic actives, while conventional forms, high vitamin B6, and an unnecessary softgel calorie load limit quality.</p>
78 Value

Coenzyme B-Complex Advanced

Country Life
<p>Active B-vitamin forms and PQQ provide a cleaner energy-focused strategy at lower serving cost. The formula lacks the original’s circulation, phospholipid, adaptogen, and cholinergic coverage, and aggressive B6 and niacin amounts reduce routine-use suitability.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledCognitive Support forGinkgo
  2. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledCognitive Support Brain Health Productivity Boost forGinkgo
  3. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  4. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsCognitive Support Brain Health forAcetyl L-Carnitine
  5. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsCognitive Support Brain Health forAcetyl L-Carnitine
  6. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.
    Thal LJ; Calvani M; Amato A; Carta A · Neurology · 2000
    Randomized trial229 participantsCognitive Support forAcetyl L-Carnitine
  7. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.
    Rai G; Wright G; Scott L; Beston B; Rest J; Exton-Smith AN · Current medical research and opinion · 1990
    Randomized trial36 participantsCognitive Support forAcetyl L-Carnitine
  8. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
    Malaguarnera G; Catania VE; Bertino G; Chisari LM; Castorina M; Bonfiglio C; Cauli O; Malaguarnera M · Current pharmaceutical design · 2022
    Randomized trial92 participantsAnti-Aging forAcetyl L-Carnitine
  9. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males.
    Lopresti AL; Drummond PD; Smith SJ · American journal of men's health · 2020
    Randomized trial57 participantsAnti-Aging forAshwagandha
  10. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  11. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  12. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  13. Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.
    Leonard M; Dickerson B; Estes L; Gonzalez DE; Jenkins V; Johnson S; Xing D; Yoo C; Ko J; Purpura M; Jäger R; Faries M; Kephart W; Sowinski R; Rasmussen CJ; Kreider RB · Nutrients · 2024
    Randomized trial59 participantsBrain Health Cognitive Support forAshwagandha
  14. Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study.
    Rai HP; Mishra DN · Journal of psychopharmacology (Oxford, England) · 2025
    Randomized trial40 participantsBrain Health Cognitive Support forAshwagandha
  15. Efficacy of Withania somnifera supplementation on adult's cognition and mood.
    Remenapp A; Coyle K; Orange T; Lynch T; Hooper D; Hooper S; Conway K; Hausenblas HA · Journal of Ayurveda and integrative medicine · 2022
    Randomized trial60 participantsBrain Health Cognitive Support forAshwagandha
  16. A clinical assessment of the therapeutic effects of Ashwagandha root extract on cognitive performance, sleep, and fatigue in children aged 6-12 years.
    Saxena A; Lopresti A; Sharif M; Elon N; Suri R; Langade DK · Frontiers in nutrition · 2026
    Randomized trial85 participantsBrain Health forAshwagandha
  17. Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study.
    Gopukumar K; Thanawala S; Somepalli V; Rao TSS; Thamatam VB; Chauhan S · Evidence-based complementary and alternative medicine : eCAM · 2022
    Randomized trial130 participantsBrain Health forAshwagandha
  18. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  19. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  20. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  21. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  22. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
    Xing SH; Zhu CX; Zhang R; An L · Evidence-based complementary and alternative medicine : eCAM · 2014
    Meta-analysis825 participants10 studies pooledBrain Health Cognitive Support forHuperzine
  23. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
    Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G · Zhonghua yi xue za zhi · 2002
    Randomized trial202 participantsBrain Health Cognitive Support forHuperzine
  24. Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
    Zhang Z; Shen Y; Li J; Tang Y; Zhou P; Ying T; Mo R; Ru Z; Zhao G; Zhu J; Li S; Zhao H · International journal of surgery (London, England) · 2026
    Randomized trial123 participantsBrain Health Cognitive Support forHuperzine
  25. Treatment with Huperzine A improves cognition in vascular dementia patients.
    Xu ZQ; Liang XM; Juan-Wu; Zhang YF; Zhu CX; Jiang XJ · Cell biochemistry and biophysics · 2012
    Randomized trial78 participantsBrain Health forHuperzine
  26. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
    Gul A; Bakht J; Mehmood F · Journal of the Chinese Medical Association : JCMA · 2019
    Randomized trial100 participantsBrain Health forHuperzine
  27. Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury.
    Zhang P; Cao Y; Chen S; Shao L · Pharmacology · 2021
    Randomized trial60 participantsBrain Health forVinpocetine
  28. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
    Szilágyi G; Nagy Z; Balkay L; Boros I; Emri M; Lehel S; Márián T; Molnár T; Szakáll S; Trón L; Bereczki D; Csiba L; Fekete I; Kerényi L; Galuska L; Varga J; Bönöczk P; Vas A; Gulyás B · Journal of the neurological sciences · 2005
    Randomized trial13 participantsBrain Health forVinpocetine
  29. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
    Bönöczk P; Gulyás B; Adam-Vizi V; Nemes A; Kárpáti E; Kiss B; Kapás M; Szántay C; Koncz I; Zelles T; Vas A · Brain research bulletin · 2001
    Narrative reviewBrain Health forVinpocetine
  30. Effect of vinpocetine (cognitol™) on cognitive performances of a nigerian population.
    Ogunrin A · Annals of medical and health sciences research · 2014
    Non-randomized trial112 participantsBrain Health Mental Focus forVinpocetine
  31. [Study of the effects of vinpocetin on cognitive functions].
    Valikovics A; Csányi A; Németh L · Ideggyogyaszati szemle · 2012
    Clinical trialBrain Health forVinpocetine
  32. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  33. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  34. A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study.
    Majeed M; Nagabhushanam K; Mundkur L · Medicine · 2023
    Randomized trial54 participantsCognitive Support forAshwagandha
  35. Efficacy and safety of ashwagandha root extract in children and adolescents with mild attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial.
    Naik S; Muralidhar G; Rao BS; Agarwal S; Jain M · Journal of medicine and life · 2026
    Randomized trial58 participantsCognitive Support forAshwagandha
  36. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  37. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  38. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  39. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  40. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT · Human psychopharmacology · 2017
    Meta-analysis1,117 participants12 studies pooledCognitive Support forHuperzine
  41. [Drug evaluation of huperzine A in the treatment of senile memory disorders].
    Zhang RW; Tang XC; Han YY; Sang GW; Zhang YD; Ma YX; Zhang CL; Yang RM · Zhongguo yao li xue bao = Acta pharmacologica Sinica · 1992
    Randomized trial56 participantsCognitive Support forHuperzine
  42. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F · The American journal of clinical nutrition · 2011
    Randomized trial121 participantsEnergy forAcetyl L-Carnitine
  43. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
    Malaguarnera M; Vacante M; Bertino G; Neri S; Malaguarnera M; Gargante MP; Motta M; Lupo L; Chisari G; Bruno CM; Pennisi G; Bella R · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Randomized trial60 participantsEnergy forAcetyl L-Carnitine
  44. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
    Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G · Scandinavian journal of gastroenterology · 2011
    Randomized trial67 participantsEnergy forAcetyl L-Carnitine
  45. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
    Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y · Experimental and therapeutic medicine · 2020
    Randomized trial239 participantsEnergy forAcetyl L-Carnitine
  46. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
    Kumar R; Nuñez NA; Joshi N; Joseph B; Verde A; Seshadri A; Cuellar Barboza AB; Prokop LJ; Medeiros GC; Singh B · Bipolar disorders · 2024
    Systematic reviewEnergy forAcetyl L-Carnitine
  47. A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults.
    Deshpande A; Irani N; Balkrishnan R; Benny IR · Sleep medicine · 2021
    Randomized trial150 participantsGeneral Health forAshwagandha
  48. Effects of Ashwagandha ( Withania somnifera) standardized root extract on physical endurance and VO 2max in healthy adults performing resistance training: An eight-week, prospective, randomized, double-blind, placebo-controlled study.
    Verma N; Gupta SK; Patil S; Tiwari S; Mishra AK · F1000Research · 2024
    Randomized trial80 participantsGeneral Health forAshwagandha
  49. Efficacy of Ashwagandha (Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults.
    Choudhary B; Shetty A; Langade DG · Ayu · 2016
    Randomized trial50 participantsGeneral Health forAshwagandha
  50. Withania somnifera (L.) Dunal as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study.
    Singh P; Salman KA; Shameem M; Warsi MS · Frontiers in pharmacology · 2022
    Randomized trial150 participantsGeneral Health forAshwagandha
  51. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis.
    Cheah KL; Norhayati MN; Husniati Yaacob L; Abdul Rahman R · PloS one · 2021
    Meta-analysis400 participants5 studies pooledGeneral Health forAshwagandha
  52. Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
    Malaguarnera G; Pennisi M; Gagliano C; Vacante M; Malaguarnera M; Salomone S; Drago F; Bertino G; Caraci F; Nunnari G; Malaguarnera M · Hepatitis monthly · 2014
    Randomized trial62 participantsMental Focus Productivity Boost forAcetyl L-Carnitine
  53. [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
    Lino A; Boccia MM; Rusconi AC; Bellomonte L; Cocuroccia B · La Clinica terapeutica · 1992
    Non-randomized trial17 participantsMental Focus forAcetyl L-Carnitine
  54. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
    Arnold LE; Amato A; Bozzolo H; Hollway J; Cook A; Ramadan Y; Crowl L; Zhang D; Thompson S; Testa G; Kliewer V; Wigal T; McBurnett K; Manos M · Journal of child and adolescent psychopharmacology · 2008
    Randomized trial112 participantsMental Focus forAcetyl L-Carnitine
  55. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE · The Cochrane database of systematic reviews · 2019
    Meta-analysis398 participants5 studies pooledMental Focus forAcetyl L-Carnitine
  56. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  57. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  58. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  59. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  60. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  61. "Brain-specific" nutrients: a memory cure?
    McDaniel MA; Maier SF; Einstein GO · Nutrition (Burbank, Los Angeles County, Calif.) · 2004
    Narrative reviewMental Focus forVinpocetine
  62. Psychopharmacological effects of vinpocetine in normal healthy volunteers.
    Subhan Z; Hindmarch I · European journal of clinical pharmacology · 1985
    Randomized trial12 participantsMental Focus forVinpocetine
  63. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  64. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  65. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  66. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  67. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  68. Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.
    Wessinger CM; Inman CL; Weinstock J; Weiss EP · International journal of exercise science · 2025
    Randomized trial15 participantsProductivity Boost forHuperzine
  69. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  70. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  71. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  72. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  73. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo
  74. [Effect of vasoactive agents on visual functions and ocular blood flow in patients with early manifestations of age-related macular degeneration].
    Avetisov SE; Kiseleva TN; Lagutina IuM; Kravchuk EA · Vestnik oftalmologii · 2007
    Non-randomized trial40 participantsVision Support forVinpocetine